Lilly Warns of Impurities in Compounded Weight Loss Drugs: What You Need to Know
Eli Lilly has issued a public warning regarding potential health risks associated with compounded weight-loss drugs containing vitamin B12 and tirzepatide, the active ingredient in its medications Zepbound and Mounjaro. The company’s testing revealed a previously unidentified impurity arising during the compounding process, raising concerns about patient safety.
The Issue: Tirzepatide and Vitamin B12 Interaction
Lilly’s laboratory tests found that combining tirzepatide with vitamin B12 results in a chemical reaction, creating a molecule different from tirzepatide alone. This new molecule’s impact on how the drug is absorbed, metabolized, and eliminated by the body is currently unknown. The company states that the short- and long-term effects of this impurity in humans are also unknown, as is its potential impact on the drug’s efficacy, toxicity, or immune reactions.
The testing, conducted on ten samples obtained from compounding pharmacies, medspas, and telehealth networks, consistently identified “significant levels” of this impurity. Some samples showed inconsistent potency, with as little as 43% of the labeled drug amount.
FDA-Approved vs. Compounded Medications: A Critical Difference
The core of the issue lies in the distinction between FDA-approved drugs like Zepbound and Mounjaro, and compounded medications. FDA-approved drugs undergo rigorous testing for safety and effectiveness. Compounded medications, still, do not receive the same level of scrutiny.
Zepbound is approved for chronic weight management and obstructive sleep apnea, although Mounjaro is approved for type 2 diabetes. Compounding pharmacies are permitted to create customized medications when a patient requires a specific formulation not commercially available, such as including vitamins or adjusting dosages. However, the recent findings raise questions about the safety of these compounded formulations.
Why the Combination? The Appeal of Compounded GLP-1s
Compounded versions of GLP-1 medications gained popularity during shortages of brand-name drugs. Even now, some compounders add vitamins like B12 to offer lower-cost alternatives and market them as personalized formulations. Some claim adding B12 may help address fatigue, particularly in individuals with a vitamin deficiency.
However, there is no evidence to support the safety or efficacy of combining B12 directly with tirzepatide injections. Other additives found in compounded samples, such as glycine and niacinamide, also lack sufficient safety and efficacy data.
Industry Response: Concerns and Questions
The Alliance for Pharmacy Compounding (APC) acknowledged the report but expressed concerns about the lack of detail provided by Lilly. Scott Brunner, CEO of the APC, noted that there has been no alarming trend of adverse events reported with compounded tirzepatide and B12 over the past four years. He also questioned the source of Lilly’s samples, suggesting that drugs from unlicensed sources may not meet the same standards as those from state-licensed compounding pharmacies.
What Should Patients Do?
Experts recommend that individuals currently using compounded GLP-1 medications discuss alternative treatment options with their healthcare provider. If affordability or insurance coverage is a concern, exploring options for obtaining FDA-approved GLP-1s for conditions like obstructive sleep apnea or type 2 diabetes may be beneficial. The price gap between compounded and brand-name medications has also narrowed in some cases.
Zepbound vs. Mounjaro: A Quick Recap
Both Zepbound and Mounjaro contain tirzepatide, manufactured by Eli Lilly. The key difference lies in their FDA approval: Zepbound for weight management and obstructive sleep apnea, and Mounjaro for type 2 diabetes. Insurance coverage can also vary significantly between the two.
FAQ
- What is tirzepatide? Tirzepatide is the active ingredient in both Zepbound and Mounjaro.
- Is it safe to utilize compounded GLP-1 medications? The FDA has not approved compounded GLP-1s, and recent findings raise concerns about impurities and inconsistent potency.
- What should I do if I’m currently using a compounded version? Talk to your doctor about alternative treatment options.
- What is the difference between Zepbound and Mounjaro? Zepbound is approved for weight loss and OSA, while Mounjaro is approved for type 2 diabetes.
Pro Tip: Always discuss any medication changes with your healthcare provider to ensure your safety and optimize your treatment plan.
Have questions about Zepbound, Mounjaro, or compounded medications? Share your thoughts in the comments below!
